Spider peptide toxins as leads for drug development

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.2, Iss.6, 2007-06, pp. : 823-835

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Products as Leads for Tuberculosis Drug Development

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-04 ,pp. : 735-765

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals as Prototypes for Pharmaceutical Leads Towards Drug Development Against Diabetic Cardiomyopathy

Current Pharmaceutical Design, Vol. 22, Iss. 20, 2016-06 ,pp. : 3058-3070

Bentham Science Publishers

Access to resources Recommend Favorite

Non-peptide G-protein activators as promising tools in cell biology and potential drug leads

By Nurnberg B. Togel W. Krause G. Storm R. Breitweg-Lehmann E. Schunack W.

European Journal of Medicinal Chemistry, Vol. 34, Iss. 1, 1999-01 ,pp. : 5-30

Elsevier

Access to resources Recommend Favorite

Fishing for new drug leads

By Craik D.

Trends in Pharmacological Sciences, Vol. 22, Iss. 5, 2001-05 ,pp. : 261-261

Elsevier

Access to resources Recommend Favorite

Natural products as drug leads

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1915-1918

Informa Healthcare

Access to resources Recommend Favorite